SSSW(SH:688399)2024-04-26 09:21Revenue Performance - Revenue for Q1 2024 was CNY 91,119,399.55, a decrease of 3.12% compared to the same period last year[5]. - Total revenue for Q1 2024 was CNY 91,119,399.55, a decrease of 3.1% compared to CNY 94,053,695.57 in Q1 2023[20]. - Total revenue from sales and services in Q1 2024 was ¥133,113,555.64, down 37.8% from ¥214,177,789.24 in Q1 2023[24]. Profitability - Net profit attributable to shareholders increased by 306.28% to CNY 40,067,958.01[5]. - The net profit for Q1 2024 was ¥40,067,958.01, a significant recovery from a net loss of ¥19,424,028.96 in Q1 2023, marking a turnaround of over 300%[22]. - Operating profit for Q1 2024 reached ¥40,142,643.98, compared to an operating loss of ¥18,851,172.31 in the same period last year[22]. - The company reported a total profit of ¥40,163,603.78 for Q1 2024, compared to a total loss of ¥18,288,639.26 in the same quarter last year[22]. Earnings Per Share - Basic and diluted earnings per share were both CNY 0.68, reflecting a growth of 306.06%[6]. - Basic and diluted earnings per share for Q1 2024 were both ¥0.68, recovering from a loss of ¥0.33 per share in Q1 2023[22]. Cash Flow - Operating cash flow net amount increased by 123.32% to CNY 52,790,211.13[5]. - Cash flow from operating activities generated a net inflow of ¥52,790,211.13, a recovery from a net outflow of ¥226,392,877.94 in the previous year[25]. - Investment activities produced a net cash inflow of ¥320,843,883.16, contrasting with a net outflow of ¥209,951,069.10 in Q1 2023[25]. - Cash and cash equivalents increased to CNY 2,293,637,428.80 as of March 31, 2024, compared to CNY 1,769,363,902.73 at the end of 2023[14]. - Cash and cash equivalents at the end of Q1 2024 totaled ¥2,154,466,060.59, up from ¥979,636,103.79 at the end of Q1 2023, indicating a growth of 120%[26]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,033,250,487.34, an increase of 3.25% from the previous year[6]. - Total assets reached CNY 4,033,250,487.34 as of March 31, 2024, up from CNY 3,906,413,426.27 at the end of 2023[17]. - Total liabilities amounted to CNY 588,078,624.22, an increase from CNY 501,309,521.16 at the end of 2023[16]. - The company's total equity as of March 31, 2024, was CNY 3,445,171,863.12, up from CNY 3,405,103,905.11 at the end of 2023[17]. Research and Development - R&D investment totaled CNY 19,762,499.26, a decrease of 42.36% year-on-year, accounting for 21.69% of revenue[6]. - Research and development expenses for Q1 2024 were ¥19,762,499.26, a decrease from ¥34,288,082.49 in Q1 2023, reflecting a reduction of approximately 42%[21]. Shareholder Information - The company had 8,818 common shareholders at the end of the reporting period[10]. Non-Recurring Gains and Losses - Non-recurring gains and losses amounted to CNY 25,193,885.44, primarily from government subsidies and asset disposals[7]. Inventory and Borrowings - Inventory increased to CNY 104,248,482.78 in Q1 2024, compared to CNY 93,859,936.04 in Q4 2023[15]. - Short-term borrowings rose to CNY 310,043,171.55 in Q1 2024, compared to CNY 156,942,328.54 in Q4 2023[16]. Other Information - The company reported a net profit margin improvement due to reduced operating costs, although specific profit figures were not disclosed[20]. - The company has not disclosed any new product developments or market expansion strategies in the current report[13].